Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker

Cite this paper

@inproceedings{Sgroi2013PredictionOL, title={Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker}, author={Dennis C. Sgroi and Erin M Carney and Elizabeth R Zarrella and Lauren M Steffel and Shemeica N. Binns and Dianne M. Finkelstein and Jackie D Szymonifka and Atul K. Bhan and Lois E. Shepherd and Yi Zhang and Catherine A. Schnabel and Mark G. Erlander and James N. Ingle and Peggy L. Porter and Hyman Bernard Muss and Katherine I. Pritchard and Dongsheng Tu and David L . Rimm and Paul E Goss}, booktitle={Journal of the National Cancer Institute}, year={2013} }